Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer

by Dockery LE, Gunderson CC, Moore KN
Published 2017-06-01

Recent developments regarding periostin in bronchial asthma

by Kenji Izuhara, Hisako Matsumoto, Shoichiro Ohta, Junya Ono, Kazuhiko Arima, Masahiro Ogawa
Published 2015-09-01

Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe

by Tatjana Huebner, Catharina Scholl, Michael Steffens
Published 2021-06-01

Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine

by Ruben J. Colman, Jasbir Dhaliwal, Jasbir Dhaliwal, Michael J. Rosen, Michael J. Rosen
Published 2021-02-01

Efficacy of PARP Inhibitors in the Treatment of Ovarian Cancer: A Literature-Based Review

by Vikas Goswami, Venkata Pradeep Babu Koyyala, Sumit Goyal, Manish Sharma, Varun Goel, Nilesh Dhamne, Udip Maheshwari, Atul Sharma
Published 2019-01-01

Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate

by Christian Brand, Ahmad Sadique, Jacob L. Houghton, Kishore Gangangari, Jose F. Ponte, Jason S. Lewis, Naga Vara Kishore Pillarsetty, Jason A. Konner, Thomas Reiner
Published 2018-08-01

Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcin...

by Songbai Wang, Mike Burgess, Christopher Major, Alistair English, Maranna Sweeney, Arndt Hartmann
Published 2020-07-01

Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer

by Deborah L. Toppmeyer, Michael F. Press
Published 2020-09-01

Serum Periostin: A Novel Biomarker for Asthma Management

by Hisako Matsumoto
Published 2014-01-01

How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

by Mikyung Kelly Seo, John Cairns
Published 2021-09-01

Drug-diagnostics co-development in oncology

by Richard eSimon
Published 2013-12-01

A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

by Dee eLuo, Dee eLuo, James A Smith, James A Smith, Nick A Meadows, Katie eManescu, Kim eBure, Benjamin eDavies, Rob eHorne, David L DiGiusto, David A Brindley, David A Brindley, David A Brindley, David A Brindley, David A Brindley, David A Brindley
Published 2016-01-01

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

by Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez, Patricia Galván, Ana Belén Rodríguez, Antonio Martinez, Montserrat Muñoz, Aleix Prat
Published 2020-05-01

Aligning the Economic Value of Companion Diagnostics and Stratified Medicines

by Edward D. Blair, Elyse K. Stratton, Martina Kaufmann
Published 2012-11-01

Multiplexed Prostate Cancer Companion Diagnostic Devices

by Josephine Aidoo-Brown, Despina Moschou, Pedro Estrela
Published 2021-07-01

PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”

by Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, Cherie Neille, Agne Sadauskaite, Michele Moschetta, Nikolaos Zakynthinakis-Kyriakou, Nicholas Pavlidis
Published 2019-05-01

A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Diagnostic for Personalized Treatment of the BRAF-Mutation-Lik...

by Sjors G. J. G. In ’t Veld, Kim N. Duong, Mireille Snel, Anke Witteveen, Inès J. Beumer, Leonie J.M.J. Delahaye, Diederik Wehkamp, René Bernards, Annuska M. Glas, Sun Tian
Published 2017-11-01

Precision Medicine for Rheumatoid Arthritis: The Right Drug for the Right Patient—Companion Diagnostics

by Richard Thomas Meehan, Isabelle Anne Amigues, Vijaya Knight
Published 2021-07-01

Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2

by Ken Uchibori, Natsuki Takano, Ryo Manabe, Ryosuke Tsugitomi, Shinsuke Ogusu, Takehiro Tozuka, Hiroaki Sakamoto, Hiroshi Yoshida, Yoshiaki Amino, Ryo Ariyasu, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Published 2021-03-01

Personalized medicine: biomarkers and companion diagnostics

by Renato Bernardini, Giovanni Gancitano, Angela Balice, Rosaria Di Mauro, Giuseppina Cantarella, Matteo Dionisi
Published 2018-03-01